1. Finland Stocks

  2. •

    Health technology

  3. •

    Medical specialties
Revenio Group Oyj

Revenio Group Oyj

10.88
EUR
-0.26
(-2.33%)
0.42EPS
24.76P/E
279.41MMarket Cap
Nov 12Next Earn
Revenio Group Oyj
MUN:R0V
(Munich Stock Exchange)

Recent

price

10.88

P/E

ratio

24.76

div

yld

3.53%

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
EUR
1.12
0.93
0.92
0.58
0.68
0.85
0.98
1.12
1.28
1.93
2.3
2.97
3.65
3.63
3.89
4.12
4.51
Revenue per Share
-0.03
0.17
-0.01
0.19
-0.03
0.27
0.23
0.29
0.34
0.36
0.5
0.65
0.82
0.72
0.7
0.65
0.42
Basic EPS, GAAP
0.03
0.16
0.02
0.2
0.06
0.22
0.19
0.29
0.36
0.43
0.51
0.73
0.8
0.26
0.74
0.98
0.42
Free Cash Flow per Basic Share
0.03
0.07
0.07
0.21
0.1
0.15
0.23
0.25
0.26
0.26
0.3
0.32
0.34
0.36
0.38
0.4
0.38
Dividend per Share
0.61
0.71
0.64
0.64
0.52
0.65
0.76
0.67
0.75
2.43
2.63
2.95
3.42
3.76
4.05
4.31
5.62
Book Value per Share
0.2
0.32
0.26
0.24
0.35
0.45
0.5
0.49
0.53
-0.21
0.09
0.02
0.53
0.82
0.84
1.07
-6.24
Tangible Book Value per Share
23
23
23
23
24
24
24
24
24
26
27
27
27
27
27
27
28
Basic Weighted Avg Shares
26
21
21
14
16
20
23
27
31
49
61
79
97
97
104
110
124
Sales/Revenue/Turnover
3.78
15.41
20.14
31.62
27.52
28.44
30.12
30.32
33.29
23.34
29.64
28.85
30.61
27.28
24.2
23.17
14.08
Operating Margin (%)
1
1
1
- -
1
1
1
2
1
2
5
4
3
4
5
4
5
Depreciation Expense
-1
4
- -
4
-1
6
6
7
8
9
13
17
22
19
18
17
12
Net Income, GAAP
- -
29.51
3.68
29.71
19.79
22.24
21.54
17.38
20.83
23.87
20.08
21.62
25.13
24.72
24.88
23.72
30.54
Effective Tax Rate (%)
-2.28
18.23
-1.36
32.11
-4.33
32.08
23.83
25.57
26.43
18.88
21.88
21.99
22.43
19.79
17.87
15.88
9.41
Profit Margin (%)
2
4
5
5
5
10
9
11
12
22
26
- -
27
27
25
27
-75
Working Capital
1
- -
1
1
1
- -
1
- -
- -
24
22
1
15
12
7
5
7
LT Debt
14
16
15
15
12
15
15
16
18
64
70
78
91
100
108
115
150
Total Equity
- -
13.52
22.9
17.22
23.2
30.45
34.98
41.87
46.53
17.02
14.13
17
20.25
16.84
15.62
15.68
8.93
Return on Invested Capital (%)
- -
22.92
-1.08
24.97
-4.38
44.26
35.3
42.77
46.69
17.03
14.25
17.51
20.52
17.17
15.96
14.39
8.54
Return on Capital (%)
-3.95
25.62
-1.85
29.28
-5.09
46.65
35.68
43.17
47.58
22.67
19.93
23.38
25.69
20.03
17.82
15.66
8.95
Return on Common Equity (%)

Capital Structure

EUR

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
6
2
3
LT Borrowings
2
- -
- -
LT Finance Leases
4
3
7
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
27
27
27
Market Capitalization
499
416
279

Working Capital

EUR

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
53
51
105
Cash, Cash Equivalents & STI
26
21
18
Accounts Receivable, Net
11
18
43
Inventories
11
11
45
Total Current Liabilities
26
22
181
Payables & Accruals
- -
- -
- -
ST Debt
6
2
3
Deferred Revenue
- -
- -
- -

Growth Rates

EUR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
33.65%
10.52%
6.49%
Free Cash Flow
31.92%
41.19%
32.24%
Net Income, GAAP
11.92%
6.8%
-5.87%
Sales/Revenue/Turnover
19.41%
12.97%
5.95%
Total Cash Common Dividend
12.37%
6.01%
5.28%

Quarterly Revenue

EUR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
24
25
24
31
104
2025
26
27
- -
31
110
2026
27
39
- -
- -
- -

Quarterly Earnings Per Share

EUR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.14
0.15
0.16
0.25
0.7
2025
0.16
0.12
- -
0.21
0.65
2026
0.09
0.02
- -
- -
- -

Quarterly Dividends Per Share

EUR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
0.38
- -
- -
0.38
2025
- -
0.4
- -
- -
0.4
2026
- -
- -
- -
- -
- -
Similar Companies
Intuitive Surgical, Inc. (NASDAQ:ISRG)
Boston Scientific Corporation (NYSE:BSX)
Thermo Fisher Scientific Inc (NYSE:TMO)
Illumina, Inc. (NASDAQ:ILMN)
Abbott Laboratories (NYSE:ABT)
GRAIL, Inc. (NASDAQ:GRAL)
Business
Revenio Group Oyj operates as a health technology innovator, developing, producing, and distributing advanced diagnostic tools for eye care professionals worldwide. Its offerings address conditions such as glaucoma, macular degeneration, diabetic retinopathy, and cataracts across European, American, and Asian markets. The firm’s comprehensive iCare product suite features various intraocular pressure measurement devices, including the iCare IC100, IC200, and the iCare HOME2 for personal use, alongside the new iCare ST500 Slit Lamp tonometer. Imaging solutions include the iCare EIDON for true-color confocal retinal scans and the iCare DRSplus for retinal examination. Visual field analysis is provided through instruments like the iCare COMPASS and MAIA. Furthermore, Revenio delivers sophisticated software platforms such as Oculo, facilitating clinical communication, remote monitoring, and data analysis in eye care, and iCare ILLUME, an AI-powered screening tool for early disease detection. Established in 2001, Revenio Group Oyj maintains its headquarters in Vantaa, Finland.